Logo image of SGFY

SIGNIFY HEALTH INC -CLASS A (SGFY) Stock Fundamental Analysis

NYSE:SGFY - New York Stock Exchange, Inc. - US82671G1004 - Common Stock - Currency: USD

30.49  +0.02 (+0.07%)

After market: 30.49 0 (0%)

Fundamental Rating

4

Overall SGFY gets a fundamental rating of 4 out of 10. We evaluated SGFY against 102 industry peers in the Health Care Providers & Services industry. SGFY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SGFY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SGFY has reported negative net income.
In the past year SGFY had a positive cash flow from operations.
In the past 5 years SGFY reported 4 times negative net income.
Each year in the past 5 years SGFY had a positive operating cash flow.
SGFY Yearly Net Income VS EBIT VS OCF VS FCFSGFY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 -200M -400M

1.2 Ratios

SGFY has negative profitability rations, so we won't be analyzing them here.
SGFY has a better Return On Invested Capital (6.14%) than 67.26% of its industry peers.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 6.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGFY Yearly ROA, ROE, ROICSGFY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -20 -40 -60 -80

1.3 Margins

Looking at the Operating Margin, with a value of 13.53%, SGFY belongs to the top of the industry, outperforming 89.38% of the companies in the same industry.
In the last couple of years the Operating Margin of SGFY has grown nicely.
SGFY's Gross Margin of 45.33% is fine compared to the rest of the industry. SGFY outperforms 72.57% of its industry peers.
SGFY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.53%
PM (TTM) N/A
GM 45.33%
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
SGFY Yearly Profit, Operating, Gross MarginsSGFY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 20 -20 40 -40 -60

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SGFY is destroying value.
The number of shares outstanding for SGFY has been increased compared to 1 year ago.
SGFY has a worse debt/assets ratio than last year.
SGFY Yearly Shares OutstandingSGFY Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 50M 100M 150M 200M
SGFY Yearly Total Debt VS Total AssetsSGFY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

SGFY has an Altman-Z score of 3.36. This indicates that SGFY is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.36, SGFY is doing good in the industry, outperforming 76.99% of the companies in the same industry.
The Debt to FCF ratio of SGFY is 93.50, which is on the high side as it means it would take SGFY, 93.50 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SGFY (93.50) is comparable to the rest of the industry.
SGFY has a Debt/Equity ratio of 0.53. This is a neutral value indicating SGFY is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.53, SGFY is doing good in the industry, outperforming 60.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 93.5
Altman-Z 3.36
ROIC/WACC0.66
WACC9.37%
SGFY Yearly LT Debt VS Equity VS FCFSGFY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.3 Liquidity

SGFY has a Current Ratio of 1.62. This is a normal value and indicates that SGFY is financially healthy and should not expect problems in meeting its short term obligations.
SGFY's Current ratio of 1.62 is fine compared to the rest of the industry. SGFY outperforms 67.26% of its industry peers.
SGFY has a Quick Ratio of 1.62. This is a normal value and indicates that SGFY is financially healthy and should not expect problems in meeting its short term obligations.
SGFY has a better Quick ratio (1.62) than 72.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
SGFY Yearly Current Assets VS Current LiabilitesSGFY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

SGFY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -390.91%.
The Revenue has grown by 23.33% in the past year. This is a very strong growth!
SGFY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.09% yearly.
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%

3.2 Future

Based on estimates for the next years, SGFY will show a very strong growth in Earnings Per Share. The EPS will grow by 93.52% on average per year.
SGFY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.33% yearly.
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SGFY Yearly Revenue VS EstimatesSGFY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
SGFY Yearly EPS VS EstimatesSGFY Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 0 -1 -2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGFY. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 94.60, which means the current valuation is very expensive for SGFY.
SGFY's Price/Forward Earnings is on the same level as the industry average.
SGFY is valuated expensively when we compare the Price/Forward Earnings ratio to 20.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 94.6
SGFY Price Earnings VS Forward Price EarningsSGFY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SGFY.
SGFY's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 1516.44
EV/EBITDA 32.74
SGFY Per share dataSGFY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

SGFY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SGFY's earnings are expected to grow with 93.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y93.52%
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

SGFY has a Yearly Dividend Yield of 1.26%. Purely for dividend investing, there may be better candidates out there.
SGFY's Dividend Yield is rather good when compared to the industry average which is at 2.54. SGFY pays more dividend than 85.84% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, SGFY's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

SGFY does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y93.52%
EPS Next 3YN/A
SGFY Yearly Income VS Free CF VS DividendSGFY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 0 -200M -400M

More info and screens

SIGNIFY HEALTH INC -CLASS A

NYSE:SGFY (3/28/2023, 8:04:01 PM)

After market: 30.49 0 (0%)

30.49

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-07 2023-03-07/dmh
Earnings (Next)05-02 2023-05-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.46%
Ins Owner Change0%
Market Cap5.46B
Analysts70
Price Target30.01 (-1.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-788.65%
Min EPS beat(2)-1114.2%
Max EPS beat(2)-463.11%
EPS beat(4)1
Avg EPS beat(4)-261.16%
Min EPS beat(4)-1114.2%
Max EPS beat(4)761.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.89%
Min Revenue beat(2)-42.43%
Max Revenue beat(2)-11.35%
Revenue beat(4)0
Avg Revenue beat(4)-14.07%
Min Revenue beat(4)-42.43%
Max Revenue beat(4)-0.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 94.6
P/S 6.78
P/FCF 1516.44
P/OCF 171.13
P/B 8.7
P/tB N/A
EV/EBITDA 32.74
EPS(TTM)-0.32
EYN/A
EPS(NY)0.32
Fwd EY1.06%
FCF(TTM)0.02
FCFY0.07%
OCF(TTM)0.18
OCFY0.58%
SpS4.5
BVpS3.5
TBVpS-0.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 6.14%
ROICexc 9.77%
ROICexgc N/A
OM 13.53%
PM (TTM) N/A
GM 45.33%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)5.48%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y104.84%
ROICexc growth 5YN/A
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 93.5
Debt/EBITDA 2.07
Cap/Depr 52.6%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z 3.36
F-Score3
WACC9.37%
ROIC/WACC0.66
Cap/Depr(3y)53.08%
Cap/Depr(5y)45.67%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
EBIT growth 1Y26.74%
EBIT growth 3Y75.98%
EBIT growth 5YN/A
EBIT Next Year153.12%
EBIT Next 3Y41%
EBIT Next 5Y25.5%
FCF growth 1Y-96.67%
FCF growth 3Y-39.43%
FCF growth 5YN/A
OCF growth 1Y-75.44%
OCF growth 3Y-8.54%
OCF growth 5YN/A